Decentralized Clinical Trials Are Here To Stay – But How Do We Execute Them More Smoothly?

While significant progress has been made in addressing the challenges of data integration and interoperability through technology, there remains a continued effort by CROs/Sponsors to adapt approaches to the virtual/hybrid environment when engaging in the execution of phase 1-3 studies.

Join the following experts from Zelta by Merative and Veristat for an insightful discussion on best practices, including real-world use cases, for the effective implementation of DCTs:

• Walker Bradham, Product Leader, Zelta by Merative
• Pauline Justumus, Associate Director, Data Management, Veristat, Canada

Emphasis will be placed on the importance of adopting a fully unified EDC/CDMS to alleviate the burdens on users, sites, and patients. The session will also include dedicated time for a Q&A, providing an opportunity for participants to seek clarification and insights on the discussed topics.

Watch the full presentation below for insights into "workaround solutions" with clinical operations and clinical data management encountering challenges in interoperability and data integration during decentralized clinical trial execution, specialized solutions/modules tailored for DCTs, and more.